tag launch-approaches 
Pharmaceutical Technology
JULY 14, 2022
Such movements have enabled pharmaceutical companies to increase their focus on rare diseases, and the number of orphan drug launches is steadily increasing. The choice of where to launch an orphan drug is an important and difficult decision. The choice of where to launch an orphan drug is an important and difficult decision.
pharmaphorum
JANUARY 21, 2022
This evolution is leading to additional health benefits and health gains, but they are accompanied by major concerns, as very high price tags raise questions about their affordability.”. In recent years, revolutionary medicines have come with price tags to match, but this is simply a symptom of our current model.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Viseven
NOVEMBER 30, 2022
From AI-based drug discovery to running virtual cohorts for clinical trials or doing continuous manufacturing instead of batch manufacturing, from launching a project effectively to doing real-world tickets, there is technology penetration all along the value chain. about approaches and how they changed in terms of disruption.
pharmaphorum
JUNE 2, 2022
And of course, in many cases, these drugs have higher than average price tags compared to the wider market which is due to the limited – or in most cases – non-existent competition within a treatment area.”. Raising questions. While in the US, Congress has proposed limits to the Orphan Drug Tax Credit, as part of the Build Back Better Act.
pharmaphorum
MAY 24, 2021
Robb DeFilippis, managing director, life sciences, for end-to-end global creative production and sourcing partner Tag in the Americas agrees. The traditional approach has included a waterfall-type methodology where it’s very linear; content is created and delivered, but it’s not often shared across the organisation.
pharmaphorum
NOVEMBER 19, 2021
The mRNA jab, developed by Pfizer and BioNTech, launched to huge fanfare in December 2020 and promised the start of the end of the coronavirus pandemic. Indeed, the price tags for Pfizer’s and Moderna’s jabs are substantial. Janssen too launched a comms campaign – an online Facebook series discussing a variety of covid issues.
Pharmaceutical Technology
JANUARY 27, 2023
On January 18, Sanofi launched a new warranty program for its rare blood disorder drug Cablivi (caplacizumab), which tackles value-based agreements in a slightly different way. Despite these challenges, Watt predicts that warranty programs could be one of many unique ways to approach risk sharing agreements differently in the coming years.
Expert insights. Personalized for you.
59 
Let's personalize your content